Luz-Ma-Adriana Balderas-Pena

Dr. Luz-Ma-Adriana Balderas-Pena

Unidad de Investigación Biomédica 02, UMAE Hospital de Especialidades (HE), Centro Médico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), 1000 Belisario Domínguez, Colonia Independencia, Guadalajara, Jalisco 44340, México
+1
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2009 in BMC Cancer
Verified
Journal Article
Open access
PDF file
TGTrinidad Garcia-Iglesias
Trinidad Garcia-Iglesias
ATAlicia Del Toro-Arreola
Alicia Del Toro-Arreola
BABenibelks Albarran-Somoza
Benibelks Albarran-Somoza
STSusana del Toro-Arreola
Susana del Toro-Arreola
PSPedro Ernesto Sánchez-Hernandez
Pedro Ernesto Sánchez-Hernandez
ADAdrián Daneri-Navarro
Adrián Daneri-Navarro
Background: Persistent high risk HPV infection can lead to cervical cancer, the second most common malignant tumor in women worldwide. NK cells play a crucial role against tumors and virus-infected cells through a fine balance between activating and inhibitory receptors. Expression of triggering receptors NKp30, NKp44, NKp46 and NKG2D on NK cells correlates with cytolytic activity against tumor cells, but these receptors have not been studied in cervical cancer and precursor lesions. The aim of the present work was to study NKp30, NKp46, NKG2D, NKp80 and 2B4 expression in NK cells from patients with cervical cancer and precursor lesions, in the context of HPV infection. Methods: NKp30, NKp46, NKG2D, NKp80 and 2B4 expression was analyzed by flow cytometry on NK cells from 59 patients with cervical cancer and squamous intraepithelial lesions. NK cell cytotoxicity was evaluated in a 4 hour CFSE/7-AAD flow cytometry assay. HPV types were identified by PCR assays. Results: We report here for the first time that NK cell-activating receptors NKp30 and NKp46 are significantly down-regulated in cervical cancer and high grade squamous intraepithelial lesion (HGSIL) patients. NCRs down-regulation correlated with low cytolytic activity, HPV-16 infection and clinical stage. NKG2D was also down-regulated in cervical cancer patients. Conclusion: Our results suggest that NKp30, NKp46 and NKG2D down-regulation represent an evasion mechanism associated to low NK cell activity, HPV-16 infection and cervical cancer progression.

1 January 2015 in Genetics and Molecular Research
Verified
Journal Article
Closed access
SGS.A. Gutiérrez-Rubio
S.A. Gutiérrez-Rubio
Antonio Quintero RamosAntonio Quintero Ramos
Antonio Quintero Ramos
ADA. Durán-Cárdenas
A. Durán-Cárdenas
RFR.A. Franco-Topete
R.A. Franco-Topete
JCJ.M. Castro-Cervantes
J.M. Castro-Cervantes
ADAdrián Daneri-Navarro
Adrián Daneri-Navarro
MDR1, which is encoded by the ABCB1 gene, is involved in multidrug resistance (hydrophobic), as well as the elimination of xenotoxic agents. The association between ABCB1 gene polymorphisms and breast cancer risk in different populations has been described previously; however, the results have been inconclusive. In this study, we examined the association between polymorphisms 3435 C/T and 1236 C/T in the ABCB1 gene and breast cancer development in Mexican women according to their menopausal status and molecular classification. Molecular subtypes as well as allele and genotype frequencies were analyzed. A total of 248 women with initial breast cancer diagnosis and 180 ethnically matched, healthy, unrelated individuals were enrolled. Polymerase chain reaction-restriction fragment length polymorphism was performed to detect polymorphisms 3435 C/T and 1236 C/T in the ABCB1 gene. Premenopausal T allele carriers of the 3435 C/T polymorphism showed a 2-fold increased risk of breast cancer with respect to the reference and postmenopausal groups, as well as triple-negative expression regarding the luminal A/B molecular subrogated subtypes. In contrast, the CT genotype of the 1236 polymorphism was a protective factor against breast cancer. We conclude that the T allele carrier of the 3435 C/T polymorphism in the ABCB1 gene in combination with an estrogen receptor-negative status may be an important risk factor for breast cancer development in premenopausal women.

6 October 2015 in Virology Journal
Verified
Journal Article
Open access
PDF file
MFMaría Guadalupe Flores-Miramontes
María Guadalupe Flores-Miramontes
LTLuis A. Torres-Reyes
Luis A. Torres-Reyes
LALiliana Alvarado-Ruíz
Liliana Alvarado-Ruíz
SRSalvador Angel Romero-Martínez
Salvador Angel Romero-Martínez
VRVerenice Ramírez-Rodríguez
Verenice Ramírez-Rodríguez
Adriana Aguilar-LemarroyAdriana Aguilar-Lemarroy
Adriana Aguilar-Lemarroy
The Linear Array® (LA) genotyping test is one of the most used methodologies for Human papillomavirus (HPV) genotyping, in that it is able to detect 37 HPV genotypes and co-infections in the same sample. However, the assay is limited to a restricted number of HPV, and sequence variations in the detection region of the HPV probes could give false negatives results. Recently, 454 Next-Generation sequencing (NGS) technology has been efficiently used also for HPV genotyping; this methodology is based on massive sequencing of HPV fragments and is expected to be highly specific and sensitive. In this work, we studied HPV prevalence in cervixes of women in Western Mexico by LA and confirmed the genotypes found by NGS. Two hundred thirty three cervical samples from women Without cervical lesions (WCL, n = 48), with Cervical intraepithelial neoplasia grade 1 (CIN I, n = 98), or with Cervical cancer (CC, n = 87) were recruited, DNA was extracted, and HPV positivity was determined by PCR amplification using PGMY09/11 primers. All HPV- positive samples were genotyped individually by LA. Additionally, pools of amplicons from the PGMY-PCR products were sequenced using 454 NGS technology. Results obtained by NGS were compared with those of LA for each group of samples. We identified 35 HPV genotypes, among which 30 were identified by both technologies; in addition, the HPV genotypes 32, 44, 74, 102 and 114 were detected by NGS. These latter genotypes, to our knowledge, have not been previously reported in Mexican population. Furthermore, we found that LA did not detect, in some diagnosis groups, certain HPV genotypes included in the test, such as 6, 11, 16, 26, 35, 51, 58, 68, 73, and 89, which indicates possible variations at the species level. There are HPV genotypes in Mexican population that cannot be detected by LA, which is, at present, the most complete commercial genotyping test. More studies are necessary to determine the impact of HPV-44, 74, 102 and 114 on the risk of developing CC. A greater number of samples must be analyzed by NGS for the most accurate determination of Mexican HPV variants.

19 July 2021 in BMJ Open
Verified
Journal Article
Open access
PDF file
ACAlfonso Martin Cueto-Manzano
Alfonso Martin Cueto-Manzano
MEMaría Claudia Espinel-Bermúdez
María Claudia Espinel-Bermúdez
SHSandra Ofelia Hernandez-Gonzalez
Sandra Ofelia Hernandez-Gonzalez
EREnrique Rojas-Campos
Enrique Rojas-Campos
ANArnulfo Hernan Nava-Zavala
Arnulfo Hernan Nava-Zavala
HHHugo R Hernández-García
Hugo R Hernández-García
Objective To describe mortality of in-hospital patients with COVID-19 and compare risk factors between survivors and non-survivors. Design Prospective cohort of adult inpatients. Setting Tertiary healthcare teaching hospital in Guadalajara, Mexico. Participants All patients with confirmed COVID-19 hospitalised from 25 March to 7 September 2020 were included. End of study: 7 November 2020. Primary outcome measures Patient survival analysed by the Kaplan-Meier method and comparison of factors by the log-rank test. Mortality risk factors analysed by multivariate Cox’s proportional-hazard model. Results One thousand ten patients included: 386 (38%) died, 618 (61%) alive at discharge and six (0.6%) remained hospitalised. There was predominance of men (63%) and high frequency of overweight–obesity (71%); hypertension (54%); diabetes (40%); and lung (9%), cardiovascular (8%) and kidney diseases (11%); all of them significantly more frequent in non-survivors. Overweight–obesity was not different between groups, but severity of disease (Manchester Triage System and quick Sequential Organ Failure Assessment) was significantly worse in non-survivors, who were also significantly older (65 vs 45 years, respectively) and had haematological, biochemical, coagulation and inflammatory biomarkers more altered than survivors. Mortality predictors were invasive mechanical ventilation (IMV; OR 3.31, p<0.0001), admission to intensive care unit (ICU; OR 2.18, p<0.0001), age (OR 1.02, p<0.0001), Manchester Triage System (urgent OR 1.44, p=0.02; immediate/very urgent OR 2.02, p=0.004), baseline C reactive protein (CRP; OR 1.002, p=0.009) and antecedent of kidney disease (OR 1.58, p=0.04) Conclusions Mortality in hospitalised patients with COVID-19 in this emerging country centre seemed to be higher than in developed countries. Patients displayed a high frequency of risk factors for poor outcome, but the need for IMV, ICU admission, older age, more severe disease at admission, antecedent of kidney disease and higher CRP levels significantly predicted mortality.

24 July 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
Daniel Sat-MuñozDaniel Sat-Muñoz
Daniel Sat-Muñoz
BHBrenda Eugenia Martinez Herrera
Brenda Eugenia Martinez Herrera
JGJavier-Andrés González-Rodríguez
Javier-Andrés González-Rodríguez
LGLeonardo-Xicotencatl Gutiérrez-Rodríguez
Leonardo-Xicotencatl Gutiérrez-Rodríguez
BENJAMIN TRUJILLO-HERNANDEZBENJAMIN TRUJILLO-HERNANDEZ
BENJAMIN TRUJILLO-HERNANDEZ
Luz-Ma-Adriana Balderas-PenaLuz-Ma-Adriana Balderas-Pena
Luz-Ma-Adriana Balderas-Pena
In patients with head and neck cancer, malnutrition is common. Most cases are treated by chemo-radiotherapy and surgery, with adverse effects on the aerodigestive area. Clinical and biochemical characteristics, health-related quality of life, survival, and risk of death were studied. The selected subjects were divided into normal- and low-phase-angle (PA) groups and followed up for at least two years. Mean ages were 67.2 and 59.3 years for low and normal PA, respectively. Patients with PA < 4.42° had significant differences in age, anthropometric and biochemical indicators of malnutrition, and inflammatory status compared to patients with PA > 4.42°. Statistical differences were found in the functional and symptom scales, with lower functional scores and higher symptom scores in patients with low PA. Median survival was 19.8 months for those with PA < 4.42° versus 34.4 months for those with PA > 4.42° (p < 0.001).The relative risk of death was related to low PA (2.6; p < 0.001). The percentage of living patients (41.7%) is almost the same as the percentage of deceased subjects (43.1%; p = 0.002), with high death rates in patients with PA < 4.42°. Phase angle was the most crucial predictor of survival and a risk factor for death in the studied cases.

1 January 2018
Verified
Book Chapter
Closed access
BRBenjamín Rubio-Jurado
Benjamín Rubio-Jurado
Luz-Ma-Adriana Balderas-PenaLuz-Ma-Adriana Balderas-Pena
Luz-Ma-Adriana Balderas-Pena
EGEduardo E. García-Luna
Eduardo E. García-Luna
MZMaria G Zavala-Cerna
Maria G Zavala-Cerna
CRCarlos Riebeling-Navarro
Carlos Riebeling-Navarro
ANArnulfo Hernan Nava-Zavala
Arnulfo Hernan Nava-Zavala